Log in
Enquire now
‌

US Patent 11512327 Compositions and methods for delivery of AAV

Patent 11512327 was granted and assigned to Voyager Therapeutics on November, 2022 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Voyager Therapeutics
Voyager Therapeutics
0
Current Assignee
Voyager Therapeutics
Voyager Therapeutics
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
115123270
Patent Inventor Names
Todd Carter0
Jinzhao Hou0
Martin Goulet0
Mathieu E. Nonnenmacher0
Dinah Wen-Yee Sah0
Holger Patzke0
Date of Patent
November 29, 2022
0
Patent Application Number
166360940
Date Filed
August 3, 2018
0
Patent Primary Examiner
‌
Stacy B. Chen
0

The invention provides compositions and methods for the preparation, manufacture, formulation and therapeutic use of adeno-associated virus (AAV) particles for the prevention and/or treatment of diseases.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11512327 Compositions and methods for delivery of AAV

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.